- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04127032
Internet-Delivered Cognitive Behaviour Therapy for Public Safety Personnel
Internet-Delivered Cognitive Behaviour Therapy (ICBT) for Public Safety Personnel (PSP): Examination of Engagement, Outcomes, Strengths and Challenges
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Background:
Public Safety Personnel (PSP) is a term that broadly encompasses personnel who ensure the safety and security of Canadians across jurisdictions, including, but not necessarily limited to, public safety communications officials (e.g., call centre operators/dispatchers), correctional employees, firefighters, paramedics, border services personnel, operational and intelligence personnel, search and rescue personnel, and police officers. As a function of their vocations, PSP are frequently exposed to traumatic events (e.g., threatened or actual physical assaults, sexual violence, fires, and explosions) and are at risk of post-traumatic stress injuries. Results from a recent survey with a large Canadian PSP sample showed 44.5% screened positive for one or more mental health disorders, which is much higher than the 10.1% diagnostic rate among the Canadian general public. For many Canadian PSP access to in-person evidence-based care is impeded for several reasons, including preference to self-manage symptoms, geographic barriers (e.g., difficulty accessing care while deployed to remote locations), logistical barriers (e.g., shift work limits access to standard service hours), stigma (e.g., perceptions of being evaluated negatively for having mental health concerns), growing waiting-lists, and limited resources (e.g., insufficient access to mental health care coverage).
Transdiagnostic Internet-delivered cognitive behaviour therapy (ICBT) represents a convenient method for PSP to access care for mental health concerns, such as depression, anxiety, and post-traumatic stress. In transdiagnostic ICBT, clients receive access to standardized lessons that provide the same information and skills as traditional face-to-face CBT. Divergent mental health symptoms are targeted within transdiagnostic ICBT by educating clients in strategies that apply to multiple conditions (e.g., cognitive restructuring, graded exposure); this helps to ensure multiple concerns are addressed in an efficient manner. This is important given high rates of mental health comorbidity. In addition to weekly lessons, clients are encouraged to complete homework assignments to facilitate learning. Research shows that transdiagnostic ICBT is effective at reducing symptoms of anxiety, depression and trauma and there is also evidence that the findings of research trials translate into routine clinic settings. Most commonly, ICBT is delivered with brief once weekly e-therapist assistance (~20 minutes) via the telephone or secure email over ~8 weeks. There are also encouraging research results that clients can benefit with lower levels of support, such as when treatment is largely self-directed but with automated reminder emails, e-therapist monitoring and optional e-therapist support as needed by clients.
Research purpose:
The purpose of the current research project is to explore outcomes of a transdiagnostic ICBT course that is specifically tailored for PSP (e.g., case examples are relevant to PSP), referred to as the PSP Wellbeing Course. Of particular interest in this study are: 1) the usage of the PSP Wellbeing Course among PSP who are informed about the PSP Wellbeing Course (e.g., # enrolling, completion rates, use of e-therapist support); 2) outcomes of the PSP Wellbeing Course with respect to diverse outcome measures (e.g., depression, anxiety, trauma, functioning) measured at 8, 26, and 52 week follow-up; and 3) strengths and challenges of the PSP Wellbeing Course when offered to Canadian PSP. In order to take part, PSP will first complete an online questionnaire and telephone screening to assess whether they meet the following inclusion criteria: 1) 18 years of age or older; 2) resident of the Canadian provinces of Saskatchewan, Quebec, Nova Scotia, New Brunswick, Prince Edward Island or Ontario; 3) not endorsing high suicide risk or recent suicide attempts in the past year; 4) able to access and comfortable using computers and the internet; 5) not seeking help primarily for alcohol and or drugs, bipolar disorder, or psychotic symptoms; and 6) willing to provide an emergency contact unless the participant does not have a physician and the clinician assesses the need for an emergency contact as low during the telephone screening. The PSP Wellbeing Course will be delivered by trained providers with graduate training in psychology or social work or graduate students under supervision. Of note, the program was first offered in Saskatchewan and later translated to French and offered to PSP who reside in Quebec as well (update: recruitment in Quebec began on September 23, 2020). The program was also expanded to PSP in Nova Scotia, New Brunswick, and Prince Edward Island in February 2022, as well as to PSP in Ontario in March 2023. Of note, a purely self-guided version of the PSP Wellbeing Course (i.e., without therapist guidance) was made available to PSP anywhere in Canada in English on December 1st, 2021 and in French on November 19th, 2022. The primary research questions to be answered include:
- ENGAGEMENT: How many PSP will enroll in and complete the PSP Wellbeing Course? What will be the uptake of optional e-therapist support, versus 1x week or 2x week e-therapist support? What will be the length of support selected (8 week-16 week)?
- OUTCOMES: What will be the impact of the PSP Wellbeing Course on symptom improvement and functioning at 8, 26, and 52 weeks post-enrollment? What factors will predict outcomes (e.g., symptom severity, demographics, engagement)?
- IMPLEMENTATION: What are stakeholder experiences, positive and negative, with the PSP Wellbeing Course? What are the suggested improvements to ICBT to meet the needs of PSP?
Significance:
This project will provide information that will inform future use of ICBT to assist PSP with common mental health concerns. Data will be extracted and analyzed on a quarterly basis in order to provide a preliminary evaluation of engagement, outcomes and implementation experiences and determine if adjustments to ICBT are required. Once adjustments are completed or deemed unnecessary, data will be extracted and analyzed biannually.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Heather D Hadjistavropoulos, PhD
- Phone Number: 306-585-5133
- Email: heather.hadjistavropoulos@uregina.ca
Study Locations
-
-
Saskatchewan
-
Regina, Saskatchewan, Canada, S4S 0A2
- Recruiting
- Department of Psychology and Canadian Institute for Public Safety Research and Treatment
-
Contact:
- Heather D Hadjistavropoulos, PhD
- Phone Number: 306-585-5133
- Email: heather.hadjistavropoulos@uregina.ca
-
Principal Investigator:
- Heather D Hadjistavropoulos, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- 18 years of age or older
- residing in a Canadian province or territory in which PSPNET is able to offer services
- endorsing symptoms of anxiety, depression, or post-traumatic stress
- able to access a computer and internet service
- willing to provide a physician as emergency contact unless the participant does not have a physician and the clinician conducting the telephone screening assesses the need for an emergency contact to be low.
Exclusion Criteria:
- high suicide risk
- suicide attempt or hospitalization in the last year
- primary problems with psychosis, alcohol or drug problems, mania
- currently receiving regular psychological treatment for anxiety or depression
- not present in Canada during treatment
- concerns about ICBT
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Tailored ICBT for PSP
Therapist-guided, Internet-delivered cognitive behavioral therapy tailored specifically for Canadian public safety personnel.
|
A tailored ICBT intervention will be delivered to public safety personnel who report symptoms of depression, anxiety, or posttraumatic stress.
Clients will choose whether they prefer weekly therapist support, twice-weekly support, or monitored optional support.
The intervention is designed to be completed in 8 weeks, but clients will be able to extend their access to therapist support by an additional 8 weeks (i.e., up to 16 weeks in total).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in depression
Time Frame: screening and 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, 26, and 52 weeks
|
Patient Health Questionnaire - 9 Item (PHQ-9).
Higher total scores indicate greater severity of depression.
Scores range from 0 to 27.
Note: this measure is only administered at 12 and 16 weeks for clients who are still engaged in treatment at those timepoints.
|
screening and 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, 26, and 52 weeks
|
Change in anxiety
Time Frame: screening and 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, 26, and 52 weeks
|
Generalized Anxiety Disorder - 7 Item (GAD-7).
Higher total scores indicate greater severity of anxiety.
Scores range from 0 to 21. Note: this measure is only administered at 12 and 16 weeks for clients who are still engaged in treatment at those timepoints.
|
screening and 1, 2, 3, 4, 5, 6, 7, 8, 12, 16, 26, and 52 weeks
|
Change in posttraumatic stress
Time Frame: screening and 8, 26, and 52 weeks
|
PTSD Checklist for DSM-5 (PCL-5).
Higher total scores indicate greater severity of posttraumatic stress.
Scores range from 0 to 80.
|
screening and 8, 26, and 52 weeks
|
Change in posttraumatic stress
Time Frame: 1, 2, 3, 4, 5, 6, 7, 12, and 16 weeks
|
Abbreviated PTSD Checklist - Civilian Version (PCL-C).
Higher total scores indicate greater severity of posttraumatic stress.
Scores range from 5 to 30.
Note: this measure is only administered at 12 and 16 weeks for clients who are still engaged in treatment at those timepoints.
|
1, 2, 3, 4, 5, 6, 7, 12, and 16 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Alcohol use
Time Frame: screening
|
Alcohol Use Disorders Identification Test (AUDIT).
Higher scores indicate greater alcohol consumption and alcohol-related problems.
Scores ranger from 0 to 40.
|
screening
|
Drug use
Time Frame: screening
|
Drug Use Disorders Identification Test (DUDIT).
Higher scores indicate greater drug use and drug-related problems.
Scores ranger from 0 to 44.
|
screening
|
Change in social anxiety (French)
Time Frame: screening and 8, 16, 26, and 52 weeks
|
Social Interaction Phobia Scale (SIPS).
Higher total scores indicate greater severity of social anxiety.
Scores range from 0 to 56.
This measure is administered only to clients of the French version of the PSP Wellbeing Course.
Note: this measure is only administered at 16 weeks for clients who are still engaged in treatment at that time.
Note: this measure was added on September 23, 2020.
|
screening and 8, 16, 26, and 52 weeks
|
Other sleep problems
Time Frame: screening
|
SLEEP-50 Questionnaire.
This questionnaire consists of 50 items spanning 9 subscales.
However, instead of administering and scoring the entire questionnaire, we are administering only 21 items for descriptive purposes.
Note: this measure was added on December 3, 2020.
|
screening
|
Lifetime Traumatic Events History
Time Frame: screening and 52 weeks
|
Life Events Checklist for DSM-5 (LEC-5).
A checklist of common traumatic events used to establish the nature of the traumatic events a respondent has experienced.
This questionnaire is not intended to be scored.
|
screening and 52 weeks
|
Worst Traumatic Event
Time Frame: screening and 52 weeks
|
Worst Traumatic Event Questionnaire.
A checklist of common traumatic events used to establish the nature of the single worst traumatic event a respondent has experienced.
This questionnaire is not intended to be scored.
|
screening and 52 weeks
|
Change in anger
Time Frame: screening and 8, 26, and 52 weeks
|
Dimensions of Anger Reactions (DAR-5) scale.
Higher total scores indicate greater severity of anger problems.
Scores range from 0 to 20.
|
screening and 8, 26, and 52 weeks
|
Change in functioning
Time Frame: screening and 4, 8, 12, 26, and 52 weeks
|
Work and Social Adjustment Scale (WSAS).
Higher total scores indicate a greater degree of impairment.
Total scores range from 0 to 40.
Note: this measure is only administered at 12 weeks for clients who are still engaged in treatment at this timepoint.
Note: this measure replaced the Sheehan Disability Scale (SDS).
|
screening and 4, 8, 12, 26, and 52 weeks
|
Change in use of health services
Time Frame: screening and 8, 26, and 52 weeks
|
Health Service Use Questionnaire is a bespoke questionnaire that assesses the use of health services for mental health problems.
|
screening and 8, 26, and 52 weeks
|
Treatment satisfaction
Time Frame: week 8
|
Treatment Satisfaction Questionnaire.
A bespoke questionnaire consisting of 32 items with varying response formats measuring treatment satisfaction and perceived treatment credibility.
Items are not designed to be combined into a unitary measure.
|
week 8
|
Working alliance
Time Frame: week 8
|
Working Alliance Inventory - Short Revised (WAI-SR).
Higher scores indicate greater working alliance.
Scores in three distinct domains of working alliance each range from 4 to 20.
|
week 8
|
Change in panic symptoms
Time Frame: screening and 8, 26, and 52 weeks
|
Panic Disorder Severity Scale-Self Report (PDSS-SR), 2-item version.
Higher total scores indicate greater severity of panic symptoms.
Scores range from 0 to 8. Note: this measure replaced the full PDSS-SR on October 6, 2023.
|
screening and 8, 26, and 52 weeks
|
Change in social anxiety (English)
Time Frame: screening and 8, 26, and 52 weeks
|
Mini-Social Phobia Inventory (Mini-SPIN).
Higher total scores indicate greater severity of social anxiety.
Scores range from 0 to 12.
This measure is administered only to clients of the English version of the PSP Wellbeing Course.
Note: this measure replaced the 6-item version of the Social Interaction Anxiety Scale and the 6-item version of the Social Phobia Scale (SIAS-6/SPS-6) on October 6th, 2023.
|
screening and 8, 26, and 52 weeks
|
Change in sleep problems
Time Frame: screening and 8, 26, and 52 weeks
|
Insomnia Severity Index (ISI).
Higher total scores indicate greater severity of sleep problems.
Scores range from 0 to 28.
Note: this measure was added on December 3, 2020.
|
screening and 8, 26, and 52 weeks
|
Change in resiliency
Time Frame: screening and 8, 26, and 52 weeks
|
Brief Resiliency Scale (BRS).
Higher total scores indicate greater resiliency.
Total scores represent mean scores across the six items of the scale and range from 0 to 5. Note: this measure was added on December 3, 2020.
|
screening and 8, 26, and 52 weeks
|
Engagement and Homework Compliance
Time Frame: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 weeks
|
Homework Reflection.
A bespoke questionnaire consisting of 8 items with varying response formats, designed to measure engagement with treatment tasks and help alert therapists to any challenges clients face.
Items are not designed to be combined into a unitary measure.
Note: this measure is only administered at 9, 10, 11, and 12 weeks for clients who are still engaged in treatment at those timepoints.
|
1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, and 12 weeks
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Heather D Hadjistavropoulos, PhD, University of Regina
Publications and helpful links
Helpful Links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-157
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression, Anxiety
-
University Hospital, Strasbourg, FranceCompletedAnxiety Depression DisorderFrance
-
ViomeRecruitingDepression | Anxiety Disorders | Anxiety | Mental Health Disorder | Anxiety Depression | Anxiety State | Mental Health | Depression, Anxiety | Mental Health IssueUnited States
-
3-C Institute for Social DevelopmentUniversity of Miami; Stony Brook UniversityCompletedDepression | Anxiety | Depression, Anxiety | Depression in AdolescenceUnited States
-
University Hospital, Strasbourg, FranceRecruitingDepression Anxiety DisorderFrance
-
UCLH/UCL Joint Research OfficeMedical Research Council; Camden and Islington NHS Trust; Central and North West...RecruitingAnxiety Disorders | Anxiety | Anxiety Depression | CBT | Anxiety Disorders and Symptoms | Anxiety Generalized | Generalised Anxiety Disorder | Anxiety Disorder; Mixed With Depression (Mild) | Anxiety Disorder GeneralizedUnited Kingdom
-
University of Southern CaliforniaCompletedAnxiety | Depression, Anxiety | Depression Mild | Attention Concentration DifficultyUnited States
-
NeuroGlove LLCRecruitingDepression | Anxiety | Anxiety Depression | Depression, AnxietyUnited States
-
Laureate Institute for Brain Research, Inc.National Institute of Mental Health (NIMH); California Institute of TechnologyRecruitingDepression | Anxiety Disorders | Fear | Depression, Anxiety | Anxiety and Fear | Anxious DepressionUnited States
-
University of Wisconsin, MadisonNot yet recruiting
-
Northern Jiangsu People's HospitalRecruitingDepression, AnxietyChina
Clinical Trials on PSP Wellbeing Course
-
University of ReginaGovernment of CanadaRecruitingDepression | Anxiety | Posttraumatic StressCanada
-
University of ReginaGovernment of CanadaCompletedDepression | Stress Disorders, Post-Traumatic | AnxietyCanada
-
University of ReginaMinistry of Health, SaskatchewanRecruiting
-
Universite de MonctonMacquarie University, AustraliaCompletedAnxiety Disorders | Major DepressionCanada
-
University of ReginaCanadian Institutes of Health Research (CIHR)Completed
-
Norwegian Institute of Public HealthThe Dam FoundationRecruitingQuality of Life | Wellbeing | Mental Health Wellness 1Norway
-
Algenis SpAOncoclínicasRecruitingChemotherapy-induced Peripheral NeuropathyBrazil
-
Southeast University, ChinaCompletedMechanical Ventilation Complication | Acute Respiratory Failure
-
University of JyvaskylaUniversity of Helsinki; University of Eastern Finland; VTT Technical Research... and other collaboratorsCompletedOverweight | Psychological Stress | Metabolic Syndrome Risk FactorsFinland
-
Assistance Publique Hopitaux De MarseilleRecruitingProgressive Supranuclear PalsyFrance